Matthew Duncton

Matthew completed Ph.D. studies from The University of Nottingham (UK) in synthetic organic chemistry. He then commenced an industrial career in drug discovery and has worked as a medicinal chemist in the neuroscience, oncology and immunology therapeutic areas at both large and small biopharma companies in the UK & USA. Matthew is an author/inventor on more than 60 papers and patents and is a Fellow of The Royal Society of Chemistry (FRSC) and a member of The American Chemical Society (ACS). In addition to society membership, he serves on the Advisory Board of Medicinal Chemistry Communications (MedChemComm) and the official journal of The European Federation for Medicinal Chemistry (EFMC), and he is published by The Royal Society of Chemistry (RSC).